Long-Acting PTH Prodrug Granted Orphan Drug Status for Hypoparathyroidism
The Company is investigating MBX 2109 in healthy adults in an ongoing phase 1 trial.
The Company is investigating MBX 2109 in healthy adults in an ongoing phase 1 trial.
The phase 3 PaTHway trial included 82 adults with chronic hypoparathyroidism.
Takeda announced a voluntary recall of all doses of Natpara (parathyroid hormone) injection (25mcg, 50mcg, 75mcg, 100mcg) due to the possible presence of small rubber particulates in the Natpara cartridge originating from the rubber septum. Takeda is notifying healthcare professionals, patients, and specialty pharmacies regarding the recall. Natpara is supplied as a multiple-dose, dual-chamber glass…
TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore PTH to physiologic levels, normalizing blood and urinary calcium levels, serum phosphate levels and bone turnover.